[1]
2023. Pharmacotherapeutic follow-up in patients with type 1 diabetes in context of judicialization: possibility optimize costs. Brazilian Journal of Pharmaceutical Sciences. 59, (Nov. 2023), e23264. DOI:https://doi.org/10.1590/s2175-97902023e23264.